(2018). Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care. Clin Epidemiol. http://doi.org/10.2147/clep.s176142.
(2018). Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017. BMJ Open. http://doi.org/10.1136/bmjopen-2018-022768.
(2020). Comparative effects of sulfonylureas, DPP4is and SGLT2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care. Diabetes Obes Metab. http://doi.org/10.1111/dom.13970.
(2021). Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study. BMJ Open. http://doi.org/10.1136/bmjopen-2020-046912.